Nectero
Recruiting
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
This is a prospective, randomized, controlled, multi-center, clinical trial to demonstrate use of the Nectero East System for stabilization of abdominal aortic aneurysms (AAA) with a maximum diameter of 3.5-5.0 cm. Subjects with AAA will be randomized to either the standard of care control group or the study treatment group to be treated with the Nectero EAST System, an investigational minimally invasive device/drug combination product designed specifically for small and mid-sized AAA.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
16 Sep 2024.
Study ID: 854941
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
